We are upgrading the repository! We will continue our upgrade in February 2025 - we have taken a break from the upgrade to open some collections for end-of-semester submission. The MS-GIST Master's Reports, SBE Senior Capstones, and UA Faculty Publications collections are currently open for submission. Please reach out to repository@u.library.arizona.edu with your questions, or if you are a UA affiliate who needs to make content available in another collection.
Ceramide as an endothelial cell surface receptor and a lung-specific lipid vascular target for circulating ligands
Name:
staquicini-et-al-2023-ceramide ...
Size:
4.146Mb
Format:
PDF
Description:
Final Published Version
Author
Staquicini, D.I.Cardó-Vila, M.
Rotolo, J.A.
Staquicini, F.I.
Tang, F.H.F.
Smith, T.L.
Ganju, A.
Schiavone, C.
Dogra, P.
Wang, Z.
Cristini, V.
Giordano, R.J.
Ozawa, M.G.
Driessen, W.H.P.
Proneth, B.
Souza, G.R.
Brinker, L.M.
Noureddine, A.
Snider, A.J.
Canals, D.
Gelovani, J.G.
Petrache, I.
Tuder, R.M.
Obeid, L.M.
Hannun, Y.A.
Kolesnick, R.N.
Brinker, C.J.
Pasqualini, R.
Arap, W.
Affiliation
University of Arizona Cancer Center, University of ArizonaDepartment of Otolaryngology-Head and Neck Surgery, University of Arizona
Issue Date
2023-08-14
Metadata
Show full item recordPublisher
National Academy of SciencesCitation
Staquicini, D. I., Cardó-Vila, M., Rotolo, J. A., Staquicini, F. I., Tang, F. H., Smith, T. L., ... & Arap, W. (2023). Ceramide as an endothelial cell surface receptor and a lung-specific lipid vascular target for circulating ligands. Proceedings of the National Academy of Sciences, 120(34), e2220269120.Rights
© 2023 the Author(s). Published by PNAS. This open access article is distributed under Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND).Collection Information
This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.Abstract
The vascular endothelium from individual organs is functionally specialized, and it displays a unique set of accessible molecular targets. These serve as endothelial cell receptors to affinity ligands. To date, all identified vascular receptors have been proteins. Here, we show that an endothelial lung-homing peptide (CGSPGWVRC) interacts with C16-ceramide, a bioactive sphingolipid that mediates several biological functions. Upon binding to cell surfaces, CGSPGWVRC triggers ceramide-rich platform formation, activates acid sphingomyelinase and ceramide production, without the associated downstream apoptotic signaling. We also show that the lung selectivity of CGSPGWVRC homing peptide is dependent on ceramide production in vivo. Finally, we demonstrate two potential applications for this lipid vascular targeting system: i) as a bioinorganic hydrogel for pulmonary imaging and ii) as a ligand-directed lung immunization tool against COVID-19. Thus, C16-ceramide is a unique example of a lipid-based receptor system in the lung vascular endothelium targeted in vivo by circulating ligands such as CGSPGWVRC. Copyright © 2023 the Author(s). Published by PNAS.Note
Open access articleISSN
0027-8424PubMed ID
37579172Version
Final Published Versionae974a485f413a2113503eed53cd6c53
10.1073/pnas.2220269120
Scopus Count
Collections
Except where otherwise noted, this item's license is described as © 2023 the Author(s). Published by PNAS. This open access article is distributed under Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND).
Related articles
- Plasma membrane reorganization links acid sphingomyelinase/ceramide to p38 MAPK pathways in endothelial cells apoptosis.
- Authors: Niaudet C, Bonnaud S, Guillonneau M, Gouard S, Gaugler MH, Dutoit S, Ripoche N, Dubois N, Trichet V, Corre I, Paris F
- Issue date: 2017 May
- Intercellular adhesion molecule 1 engagement modulates sphingomyelinase and ceramide, supporting uptake of drug carriers by the vascular endothelium.
- Authors: Serrano D, Bhowmick T, Chadha R, Garnacho C, Muro S
- Issue date: 2012 May
- Sphingomyelinase and ceramide analogs induce vasoconstriction and leukocyte-endothelial interactions in cerebral venules in the intact rat brain: Insight into mechanisms and possible relation to brain injury and stroke.
- Authors: Altura BM, Gebrewold A, Zheng T, Altura BT
- Issue date: 2002 Jul
- Neutral sphingomyelinase inhibitor scyphostatin prevents and ceramide mimics mechanotransduction in vascular endothelium.
- Authors: Czarny M, Schnitzer JE
- Issue date: 2004 Sep
- The Acid Sphingomyelinase/ Ceramide System as Target for Ischemic Stroke Therapies.
- Authors: Mohamud Yusuf A, Hagemann N, Hermann DM
- Issue date: 2019